Skip to main content

FUNCIONES FISIOLOGICAS DE LA MITOFAGIA EN LOS FOTORRECEPTORES DE LA RETINA

PGC2018-098557-B-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2018
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The mito-QC Reporter for Quantitative Mitophagy Assessment in Primary Retinal Ganglion Cells and Experimental Glaucoma Models

  • Rosignol, Ines
  • Villarejo-Zori, Beatriz
  • Teresak, Petra
  • Sierra-Filardi, Elena
  • Pereiro, Xandra
  • Rodríguez-Muela, N.
  • Vecino, Elena
  • Vieira, Helena L. A.
  • Bell, Katharina
  • Boya, Patricia
© 2020 by the authors., Mitochondrial damage plays a prominent role in glaucoma. The only way cells can degrade whole mitochondria is via autophagy, in a process called mitophagy. Thus, studying mitophagy in the context of glaucoma is essential to understand the disease. Up to date limited tools are available for analyzing mitophagy in vivo. We have taken advantage of the mito-QC reporter, a recently generated mouse model that allows an accurate mitophagy assessment to fill this gap. We used primary RGCs and retinal explants derived from mito-QC mice to quantify mitophagy activation in vitro and ex vivo. We also analyzed mitophagy in retinal ganglion cells (RGCs), in vivo, using different mitophagy inducers, as well as after optic nerve crush (ONC) in mice, a commonly used surgical procedure to model glaucoma. Using mito-QC reporter we quantified mitophagy induced by several known inducers in primary RGCs in vitro, ex vivo and in vivo. We also found that RGCs were rescued from some glaucoma relevant stress factors by incubation with the iron chelator deferiprone (DFP). Thus, the mito-QC reporter-based model is a valuable tool for accurately analyzing mitophagy in the context of glaucoma., This research was funded by Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) PGC2018-098557-B-I00 and European Union’s Horizon 2020 research and innovation programme under grant agreement No 765912. BVZ is a recipient of PhD contract from the Fundación Tatiana Pérez de Guzmán el Bueno (Spain), PT from H2020-MSCA-ITN-2017, NRM a Juan de la Cierva Grant from Ministerio Ciencia e Innovación (Spain) and KB from DFG (Deutsche Forschungsgemeinschaft, Germany, 6619/1-1)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

HIF1α or mitophagy: which drives cardiomyocyte differentiation?

  • Villarejo-Zori, Beatriz
  • Jiménez-Loygorri, Juan Ignacio
  • Boya, Patricia
4 p.-1 fig., Research in the P.B. lab is supported by grants PGC2018-098557-B-I00 from Spain’s Ministerio Ciencia e Innovación, and funding from the European Union’s Horizon 2020 re-search and innovation programme under grant agreement No. 765912., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulation of PRKN-independent mitophagy

  • Teresak, Petra
  • Lapao, Ana
  • Subic, Nemanja
  • Boya, Patricia
  • Elazar, Zvulun
  • Simonsen, Anne
37 p.-3 fig.-1 tab., Mitochondria are dynamic, multifunctional cellular organelles that play a fundamental role in maintaining cellular homeostasis. Keeping the quality of mitochondria in check is of essential importance for functioning and survival of the cells. Selective autophagic clearance of flawed mitochondria, a process termed mitophagy, is one of the most prominent mechanisms through which cells maintain a healthy mitochondrial pool. The best-studied pathway through which mitophagy is exerted is the PINK1-PRKN pathway. However, an increasing number of studies have shown an existence of alternative pathways, where different proteins and lipids are able to recruit autophagic machinery independently of PINK1 and PRKN. The significance of PRKN-independent mitophagy pathways is reflected in various physiological and pathophysiological processes, but many questions regarding the regulation and the interplay between these pathways remain open. Here we review the current knowledge and recent progress made in the field of PRKN-independent mitophagy. Particularly we focus on the regulation of various receptors that participate in targeting impaired mitochondria to autophagosomes independently of PRKN., We are grateful for funding from the Israel Science Foundation (Grant #215/19), the Sagol Longevity Foundation, Joint NRF - ISF Research Fund (Grant #3221/19), and the Yeda-Sela Center for Basic Research, as well as the Research Council of Norway through its Centres of Excellence funding scheme (project number 262652 to AS) and FRIPRO (project number 221831 to AS) and the Norwegian Cancer Society (project number 171318 to AS). Research in PB lab is supported by (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) PGC2018-098557-B-I00 Neuroscience Projects from Fundación Tatiana Pérez de Guzmán el Bueno and 2017/BMD-3813 from Comunidad de Madrid. The first authors are supported by a Marie Skłodowska-Curie ETN grant under the European Union’s Horizon 2020 Research and Innovation Programme (Grant Agreement No 765912 DRIVE), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Autophagy induction during stem cell activation plays a key role in salivary gland self-renewal

  • Orhon, Idil
  • Rocchi, Cecilia
  • Villarejo-Zori, Beatriz
  • Serrano Martínez, Paola
  • Baanstra, Mirjam
  • Brouwer, Uilke
  • Boya, Patricia
  • Coppes, Robe
  • Reggiori, Fulvio
17 p.-6 fig, Relatively quiescent tissues like salivary glands (SGs) respond to stimuli such as injury to expand,replace and regenerate. Resident stem/progenitor cells are key in this process because, upon activation, they possess the ability to self-renew. Macroautophagy/autophagy contributes to and regulates differentiation in adult tissues, but an important question is whether this pathway promotes stem cell self-renewal in tissues. We took advantage of a 3D organoid system that allows assessing the self-renewal of mouse SGs stem cells (SGSCs). We found that autophagy in dormant SGSCs has slower flux than self-renewing SGSCs. Importantly, autophagy enhancement upon SGSCs activation is a self-renewal feature in 3D organoid cultures and SGs regenerating in vivo. Accordingly,autophagy ablation in SGSCs inhibits self-renewal whereas pharmacological stimulation promotes self-renewal of mouse and human SGSCs. Thus, autophagy is a key pathway for self-renewal activation in low proliferative adult tissues, and its pharmacological manipulation has the potential to promote tissue regeneration., F.R. is supported by Marie Skłodowska-Curie Cofund [713660], Marie Skłodowska-Curie ITN [765912], ALW Open Program [ALWOP.310]and ZonMW VICI [016.130.606] grants. R.C. and C.R. are supported by the Dutch Cancer Society [Grant number 5792 and 12458]. Patricia Boya is supported by the Ministerio de Ciencia, Innovación y Universidades (MCIU), the Agencia Estatal de Investigación (AEI),the Fondo Europeo de Desarrollo Regional (FEDER) [PGC2018-098557-B-I00] and a Marie Skłodowska-Curie ITN grant [765912]. Idil Orhon is a recipient of a FEBS postdoctoral fellowship and Beatriz Villarejo-Zori of a Fundacion Tatiana Perez de Guzman el Bueno predoctoral fellowhip., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

New insights into the role of autophagy in retinal and eye diseases

  • Villarejo-Zori, Beatriz
  • Jiménez-Loygorri, Juan Ignacio
  • Zapata-Muñoz, Juan
  • Bell, Katharina
  • Boya, Patricia
18 p.-4 fig., Autophagy is a fundamental homeostatic pathway that mediates the degradation and recycling of intracellular components. It serves as a key quality control mechanism, especially in non-dividing cells such as neurons. Proteins, lipids, and even whole organelles are engulfed in autophagosomes and delivered to the lysosome for elimination. The retina is a light-sensitive tissue located in the back of the eye that detects and processes visual images. Vision is a highly demanding process, making the eye one of the most metabolically active tissues in the body and photoreceptors display glycolytic metabolism, even in the presence of oxygen. The retina and eye are also exposed to other stressors that can impair their function, including genetic mutations and age-associated changes. Autophagy, among other pathways, is therefore a key process for the preservation of retinal homeostasis. Here, we review the roles of both canonical and non-canonical autophagy in normal retinal function. We discuss the most recent studies investigating the participation of autophagy in eye diseases such as age-related macular degeneration, glaucoma, and diabetic retinopathy and its role protecting photoreceptors in several forms of retinal degeneration. Finally, we consider the therapeutic potential of strategies that target autophagy pathways to treat prevalent retinal and eye diseases., Research in the P.B. lab is supported by funding (PGC2018-098557-B-I00) from Spain's Ministerio Ciencia e Innovación, Agencia Estatal de Investigación (AEI), the Fondo Europeo de Desarrollo Regional (FEDER), the European Union's Horizon 2020 research and innovation program (grant agreement No 765912), the Fundación Tatiana Pérez de Guzmán el Bueno Proyectos en Neurociencia 2018, and Redes de BioMedicina de la Comunidad de Madrid (BMD-3813)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Towards a better understanding of the neuro-developmental role of autophagy in sickness and in health

  • Zapata-Muñoz, Juan
  • Villarejo-Zori, Beatriz
  • Largo-Barrientos, Pablo
  • Boya, Patricia
Autophagy is a critical cellular process by which biomolecules and cellular organelles are degraded in an orderly manner inside lysosomes. This process is particularly important in neurons: these post-mitotic cells cannot divide or be easily replaced and are therefore especially sensitive to the accumulation of toxic proteins and damaged organelles. Dysregulation of neuronal autophagy is well documented in a range of neurodegenerative diseases. However, growing evidence indicates that autophagy also critically contributes to neurodevelopmental cellular processes, including neurogenesis, maintenance of neural stem cell homeostasis, differentiation, metabolic reprogramming, and synaptic remodelling. These findings implicate autophagy in neurodevelopmental disorders. In this review we discuss the current understanding of the role of autophagy in neurodevelopment and neurodevelopmental disorders, as well as currently available tools and techniques that can be used to further investigate this association., Research in the P.B. lab is supported by grant (PGC2018-098557-B-I00) from Spain’s Ministerio Ciencia e Innovación, the Agencia Estatal de Investigación (AEI), the Fondo Europeo de Desarrollo Regional (FEDER), and funding from the European Union’s Horizon 2020 Research and Innova-tion Programme under grant agreement No. 765912, Fundación Tatiana Pérez de Guzmán el Bueno Proyectos en Neurociencia 2018, and Redes de BioMedicina de la Co-munidad de Madrid, BMD-3813. JZM is a recipient of a FPU fellowship (Ministerio de Universidades)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Phenotypic assay leads to discovery of mitophagy inducers with therapeutic potential for Parkinson’s disease

  • Maestro, Inés
  • De la Ballina, Laura R.
  • Simonsen, Anne
  • Boya, Patricia
  • Martínez Gil, Ana
12 p.-9 fig.-2 tab.-1 graph. abst., Mitophagy, the selective degradation of mitochondria by autophagy, involved in important physiological processes and defects in pathways has been reported in pathological conditions, such as neurodegeneration. Thus, mitophagy is an interesting target for drug discovery programs. In this investigation, we used robust phenotypic assay to screen a set of 50 small heterocyclic compounds to identify inducers of mitophagy. We identified two compounds, VP07 and JAR1.39, that induce Parkin-dependent mitophagy. Based on structure–activity relationship studies, we proposed the ability of the compounds to act as light chain 3 (LC3) interactors, similar to cardiolipin or ceramide, triggering mitophagy via Pink1/Parkin. Finally, we show promising therapeutic applicability in a cellular model of Parkinson’s disease., This research was supported by the H2020-MSCA-ITN-2017(grant no. 765912) DRIVE project, Spain’s Ministerio de Ciencia e Innovación (grant nos. PGC2018-098557-B-I00 to P.B. and PID2019-105600RB-I00 to A.M.), FRIPRO (project no. 221831 to A.S.), and the Research Council of Norway through its Centres of Excellence funding scheme (project no.262652)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Autophagy and disease: new insights and challenges ahead

  • Boya, Patricia
2 p., Research in my laboratory is supported by funding (PGC 2018-098557-B-I00) from Spain's Ministerio Ciencia e Innovación, Agencia Estatal de Investigación (AEI), the Fondo Europeo de Desarrollo Regional (FEDER), the European Union's Horizon 2020 Research and Innovation Program (grant agreement No. 765912), the Fundación Tatiana Pérez de Guzmán el Bueno Proyectos en Neurociencia 2018, and Redes de BioMedicina de la Comunidad de Madrid (BMD-3813)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

p38 MAPK priming boosts VSMC proliferation and arteriogenesis by promoting PGC1α‑dependent mitochondrial dynamics

  • Sahún-Español, Álvaro
  • Clemente, Cristina
  • Jiménez-Loygorri, Juan Ignacio
  • Sierra-Filardi, Elena
  • Herrera-Melle, Leticia
  • Gómez-Durán, Aurora
  • Sabio, Guadalupe
  • Monsalve, María
  • Boya, Patricia
  • Arroyo, Alicia G.
17 p.-6 fig., Vascular smooth muscle cell (VSMC) proliferation is essential for arteriogenesis to restore blood flow after artery occlusion, but the mechanisms underlying this response remain unclear. Based on our previous findings showing increased VSMC proliferation in the neonatal aorta of mice lacking the protease MT4-MMP, we aimed at discovering new players in this process. We demonstrate that MT4-MMP absence boosted VSMC proliferation in vitro in response to PDGF-BB in a cell-autonomous manner through enhanced p38 MAPK activity. Increased phospho-p38 in basal MT4-MMP-null VSMCs augmented the rate of mitochondrial degradation by promoting mitochondrial morphological changes through the co-activator PGC1α as demonstrated in PGC1α−/− VSMCs. We tested the in vivo implications of this pathway in a novel conditional mouse line for selective MT4-MMP deletion in VSMCs and in mice pre-treated with the p38 MAPK activator anisomycin. Priming of p38 MAPK activity in vivo by the absence of the protease MT4-MMP or by anisomycin treatment led to enhanced arteriogenesis and improved flow recovery after femoral artery occlusion. These findings may open new therapeutic opportunities for peripheral vascular diseases., Funding was provided by the Spanish Ministerio de Ciencia e Innovación (AEI/FEDER, UE), SAF2017-83229-R and PID2020-112981RB-I00 (AGA), PID2020-114709RA-I00 (AGD), PID2019-104399RB-I00 (GS), RTI2018-093864-B-I00 (MM), PGC2018-098557-B-I00 (PB), PRE2019-088222 (JIJL) and the Spanish Ministerio de Educación, Cultura y Deporte, FPU15-05802 (LHM). ASE was supported by fellowships from Obra Social La Caixa, Ford-Apadrina La Ciencia and La Residencia de Estudiantes. AGD is an Atracción de Talento M1 Fellow from Comunidad de Madrid (Spain) [2019-T1BMD-14236]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ambra1 haploinsufficiency in CD1 mice results in metabolic alterations and exacerbates age-associated retinal degeneration

  • Ramírez-Pardo, Ignacio
  • Villarejo-Zori, Beatriz
  • Jiménez-Loygorri, Juan Ignacio
  • Sierra-Filardi, Elena
  • Alonso-Gil, Sandra
  • Mariño, Guillermo
  • de la Villa, P.
  • Fitze, Patrick S.
  • Fuentes, José M.
  • García-Escudero, Ramón
  • Ferrington, Deborah A.
  • Gómez-Sintes, Raquel
  • Boya, Patricia
22 p.-9 fig., Macroautophagy/autophagy is a key process in the maintenance of cellular homeostasis. The age-dependent decline in retinal autophagy has been associated with photoreceptor degeneration. Retinal dysfunction can also result from damage to the retinal pigment epithelium (RPE), as the RPE-retina constitutes an important metabolic ecosystem that must be finely tuned to preserve visual function. While studies of mice lacking essential autophagy genes have revealed a predisposition to retinal degeneration, the consequences of a moderate reduction in autophagy, similar to that which occurs during physiological aging, remain unclear. Here, we described a retinal phenotype consistent with accelerated aging in mice carrying a haploinsufficiency for Ambra1, a pro-autophagic gene. These mice showed protein aggregation in the retina and RPE, metabolic underperformance, and premature vision loss. Moreover, Ambra1+/gt mice were more prone to retinal degeneration after RPE stress. These findings indicate that autophagy provides crucial support to RPE-retinal metabolism and protects the retina against stress and physiological aging., This work was supported by the H2020 Excellent Science [No. 765912]; Instituto de Salud Carlos III,CiberNed [CB06/05/0041]; Spanish Ministry of Science and Innovation [RTI2018-098990-J-I00]; Spanish Ministry of Science and Innovation [PGC2018-098557-B-I00]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

BNIP3L/NIX regulates both mitophagy and pexophagy

  • Wilhelm, Léa P.
  • Zapata-Muñoz, Juan
  • Villarejo-Zori, Beatriz
  • Pellegrin, Stephanie
  • Martins Freire, Catarina
  • Toye, Ashley M.
  • Boya, Patricia
  • Ganley, Ian G.
19 p.-6 fig., Mitochondria and peroxisomes are closely related metabolic organelles, both in terms of origin and in terms of function. Mitochondria and peroxisomes can also be turned over by autophagy, in processes termed mitophagy and pexophagy, respectively. However, despite their close relationship, it is not known if both organelles are turned over under similar conditions, and if so, how this might be coordinated molecularly. Here, we find that multiple selective autophagy pathways are activated upon iron chelation and show that mitophagy and pexophagy occur in a BNIP3L/NIX-dependent manner. We reveal that the outer mitochondrial membrane-anchored NIX protein, previously described as a mitophagy receptor, also independently localises to peroxisomes and drives pexophagy. We show this process happens in vivo, with mouse tissue that lacks NIX having a higher peroxisomal content. We further show that pexophagy is stimulated under the same physiological conditions that activate mitophagy, including cardiomyocyte and erythrocyte differentiation. Taken together, our work uncovers a dual role for NIX, not only in mitophagy but also in pexophagy, thus illustrating the interconnection between selective autophagy pathways., This work was funded by an EMBO Long-Term Fellowship (LPW; ALTF 1077-2018), a grant from the Medical Research Council, UK (IGG; MC_UU_00018/2) and by Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) PGC2018-098557-B-I00 to PB., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeting retinoic acid receptor alpha-corepressor interaction activates chaperone-mediated autophagy and protects against retinal degeneration

  • Gómez-Sintes, Raquel
  • Xin, Qisheng
  • Jiménez-Loygorri, Juan Ignacio
  • McCabe, Mericka
  • Díaz, Antonio
  • Garner, Thomas P.
  • Cotto-Rios, Xiomaris M.
  • Wu, Yang
  • Dong, Shuxian
  • Reynolds, Cara A.
  • Patel, Bindi
  • de la Villa, P.
  • Macian, Fernando
  • Boya, Patricia
  • Gavathiotis, Evripidis
  • Cuervo, Ana Maria
18 p.-8 fig., Chaperone-mediated autophagy activity, essential in the cellular defense against proteotoxicity, declines with age, and preventing this decline in experimental genetic models has proven beneficial. Here, we have identified the mechanism of action of selective chaperone-mediated autophagy activators previously developed by our group and have leveraged that information to generate orally bioavailable chaperone-mediated autophagy activators with favorable brain exposure. Chaperone-mediated autophagy activating molecules stabilize the interaction between retinoic acid receptor alpha - a known endogenous inhibitor of chaperone-mediated autophagy - and its co-repressor, nuclear receptor corepressor 1, resulting in changes of a discrete subset of the retinoic acid receptor alpha transcriptional program that leads to selective chaperone-mediated autophagy activation. Chaperone-mediated autophagy activators molecules activate this pathway in vivo and ameliorate retinal degeneration in a retinitis pigmentosa mouse model. Our findings reveal a mechanism for pharmacological targeting of chaperone-mediated autophagy activation and suggest a therapeutic strategy for retinal degeneration., This work was supported by National Institutes of Health grants AG054108, AG021904, and AG017617 (to AMC) and AG038072 (to AMC, FM, and EG), the JPB Foundation (to AMC), the Michael J. Fox Foundation (to AMC and EG), the Rainwater Charitable Foundation (to AMC and EG) and the Backus Foundation (to AMC). Chemical synthesis, NMR and MS data were in part supported by NIH awards P30 CA013330 and 1S10OD016305. Research in PB and RGS lab is funded by Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) PGC2018-098557-B-I00 to PB and RTI2018-098990-J-I00 to RGS. CAR was supported by T32 GM007491 and MM by T32 AG023475., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

El activador de autofagia urolitina A y su viaje al cerebro: lecciones de un modelo de envejecimiento fisiológico en ratones

  • Espín de Gea, Juan Carlos
  • Jiménez-Loygorri, Juan Ignacio
  • Viedma-Poyatos, Álvaro
  • Frutos-Lisón, M.D.
  • Tomás-Barberán, Francisco Abraham
  • Boya, Patricia
Antecedentes y objetivo: Existe controversia para identificar qué metabolito final ejerce actividad biológica tras el consumo de polifenoles. El ácido elágico (nueces, fresas, granada, etc.) es metabolizado por la microbiota intestinal hasta urolitinas, metabolitos anti-inflamatorios, antiproliferativos, neuroprotectores, moduladores de la microbiota intestinal y protectores de la barrera intestinal. Urolitina-A (Uro-A) induce autofagia en modelos murinos de enfermedades del sistema nervioso central (SNC). Sin embargo, se desconoce si llega al parénquima cerebral para ejercer estos efectos. Nuestro objetivo es explorar los efectos de Uro-A en un modelo de ratón de envejecimiento fisiológico y comprobar si Uro-A y/o sus metabolitos de fase-II llegan al cerebro. Métodos y resultados: Administramos 2,3 mg de Uro-A i.p. diariamente (~14 mg/persona de 70 kg) en ratones jóvenes (6 m) y viejos (22 m) durante 8 semanas. Realizamos electrorretinogramas, pruebas de comportamiento, histología de retina, análisis de mitofagia y del metabolismo de Uro-A (UPLC-QTOF-MS). Uro-A mejoró el índice neurodegenerativo, memoria visual, daño oxidativo, integridad sináptica, gliosis, visión nocturna y mitofagia, especialmente en ratones viejos. Un estudio cinético mostró pico de Uro-A, Uro-A-sulfato y Uro-A-glucurónido en plasma, y de forma relevante, Uro-A y Uro-A-sulfato, pero no Uro-A-glucurónido en cerebro perfundido, 30 minutos tras administrar Uro-A. Conclusiones: Uro-A ejerce neuroprotección previniendo deterioro del SNC asociado al envejecimiento. La llegada al cerebro de Uro-A y Uro-A-sulfato tras administrar Uro-A vía i.p., sugiere que cruzan la barrera hematoencefálica. Uro-A-sulfato podría ser un reservorio para liberar Uro-A tras desconjugación por arilsulfatasas cerebrales. Sin embargo, Uro-A-glucurónido, relevante en humanos, no llega al cerebro., NEURO-AGING+ (Plataforma Temática Interdisciplinar del CSIC, PTI+), y PID2019-103914RB-I00 y PGC2018-098557-B-I00 (MICINN, España)., Peer reviewed